Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chatzipanagiotou, S.
Right arrow Articles by Legakis, N. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chatzipanagiotou, S.
Right arrow Articles by Legakis, N. I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2002) 49, 803-805
© 2002 The British Society for Antimicrobial Chemotherapy

Antimicrobial susceptibility patterns of Campylobacter jejuni strains isolated from hospitalized children in Athens, Greece

S. Chatzipanagiotou1,*, E. Papavasileiou2, A. Lakumenta2, A. Makri2, C. Nicolaou1, K. Chantzis1, S. Manganas1 and N. I. Legakis3

1Department of Clinical Microbiology, Athens Medical School, Aeginition Hospital, Vass. Sophias av. 72–74, 115 28 Athens; 2Department of Microbiology, Penteli Children’s Hospital, Athens; 3Department of Microbiology, Athens Medical School, Athens, Greece

Received 27 March 2001; returned 6 December 2001; revised 15 January 2002; accepted 23 January 2002.

The antimicrobial susceptibility of 129 Campylobacter jejuni strains, isolated from hospitalized children with gastroenteritis, to five antimicrobials, including nalidixic acid, ciprofloxacin, erythromycin, ampicillin and co-amoxiclav, was determined. Isolates belonged to two time periods: group A contained strains isolated in 1987–1988; and group B 1998–2000. Antimicrobial susceptibility patterns differed significantly between the two groups with respect to quinolones, with an increase in the percentage of resistant strains in group B (30.6% versus 0% in group A), whereas erythromycin, ampicillin and co-amoxiclav were effective drugs in both groups.

* Corresponding author. Tel: +30-1-7289192; Fax: +30-1-6004608; E-mail: chatlouk{at}hotmail.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
R. Krausse and U. Ullmann
In Vitro Activities of New Fluoroquinolones against Campylobacter jejuni and Campylobacter coli Isolates Obtained from Humans in 1980 to 1982 and 1997 to 2001
Antimicrob. Agents Chemother., September 1, 2003; 47(9): 2946 - 2950.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. Wagner, M. Jabbusch, M. Eisenblatter, H. Hahn, C. Wendt, and R. Ignatius
Susceptibilities of Campylobacter jejuni Isolates from Germany to Ciprofloxacin, Moxifloxacin, Erythromycin, Clindamycin, and Tetracycline
Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2358 - 2361.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.